The Sei Foundation is reportedly exploring the acquisition of a US genomics company, potentially 23andMe, to leverage genetic information within a blockchain environment. CoinDesk reported the potential move, highlighting 23andMe's vast database of genetic information from approximately 15 million individuals. This strategic consideration comes as 23andMe faces Chapter 11 bankruptcy, prompting the Sei Foundation to view the acquisition as a crucial step for decentralized science (DeSci). The Foundation emphasizes the importance of securing genetic data, framing it as a matter of national security. Their statement underscores the vision of empowering users with direct control over their personal data. While the acquisition could rescue a struggling company, its primary goal is to pioneer a future where individual data ownership is paramount within a secure blockchain framework. The potential implications for personalized medicine and data privacy are significant. ```